Comments on: "Is percutaneous sigmoidopexy a useful alternative to high surgical risk patients to treat sigmoid volvulus".

We read with great interest the article written by Tapiolas et al. on percutaneous sigmoidopexy (PS) in sigmoid volvulus (SV). Although SV is not an over-rife disease worldwide, Eastern Anatolia is an endemic area of SV. As a result, our 1,101 patients with SV treated over 59.5 years (between June 1966 and January 2026) constitute the most comprehensive single-centre SV series over the world. Based on this clinical practice, our comments relate to PS in SV.